EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of substitutive growth hormone therapy on myopia control among Chinese children

Yi Lu, Jiamin Xie, Lele Cheng, Qingdong Fu, Miao Wu, Ji Jin, Xun Xu

Asia-Pacific Journal of Ophthalmology · 2025

DOI: 10.1016/j.apjo.2025.100137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2025. Verfasst von Yi Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research…. Hauptthemen laut MEDLINE: Human Growth Hormone, Refraction, Ocular, Myopia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To explore the correlation between recombinant human growth hormone (rhGH) therapy and myopia progression, and to optimize the myopia control strategies in myopic children undergoing rhGH therapy. METHODS: This retrospective study included 27 myopic children receiving rhGH therapy and 57 myopic children in the control group, all of whom underwent myopia interventions. Axial length (AL) and refraction were measured by IOLMaster and an autorefractor after cycloplegia. AL changes were compared between the rhGH and control groups, before and after rhGH therapy, and among different myopia control strategies. Univariate and multivariate regression models analyzed factors associated with axial elongation. RESULTS: The rhGH group exhibited greater median AL change than the control group (0.29 mm/year; interquartile range [IQR], 0.19-0.40; n = 27 vs. 0.18 mm/year; IQR, 0.12-0.27; n = 57; P < 0.001). Median axial elongation increased after rhGH treatment (0.22 mm/year; IQR, 0.12-0.34 vs. 0.32 mm/year; IQR, 0.26-0.40; n = 14; P = 0.026), while it decreased after cessation (0.39 mm/year; IQR, 0.16-0.56 vs. 0.04 mm/year; IQR, -0.03-0.15; n = 6; P = 0.031). After adjusting for confounders, axial elongation was faster in the rhGH group (β = 0.13, P < 0.001). Longer rhGH therapy duration and shorter myopia control duration were associated with accelerated axial elongation (β = 0.13, P = 0.027). Dual-therapy myopia control appeared to mitigate excessive axial elongation in rhGH-treated children more effectively than monotherapy (0.27 mm/year; IQR, 0.18-0.31; n = 20 vs. 0.40 mm/year; IQR, 0.32-0.70; n = 7; P = 0.026). CONCLUSIONS: Myopic children undergoing rhGH therapy would exhibit accelerated axial elongation despite myopia control. Close monitoring and dual-therapy myopia control strategies are recommended for these children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneRefraction, OcularMyopiaHumansRetrospective StudiesMaleChildFemaleAxial Length, EyeChinaDisease ProgressionAdolescentRecombinant ProteinsFollow-Up StudiesEast Asian People

Stichwörter der Autor:innen

Axial lengthMyopia controlMyopia progressionRecombinant human growth hormone

Substanzen

Human Growth HormoneRecombinant Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Eye Diseases, Shanghai, China; Shanghai Key Laboratory of…
  • Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
  • Hangzhou Chaoju Eye Hospital, Hangzhou, Zhejiang Province, China.
  • Hangzhou Chaoju Eye Hospital, Hangzhou, Zhejiang Province, China. Electronic address: jinji2@sina.com.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lu, Y., Xie, J., Cheng, L., Fu, Q., Wu, M., Jin, J., & Xu, X. (2025). Effect of substitutive growth hormone therapy on myopia control among Chinese children. Asia-Pacific Journal of Ophthalmology. https://doi.org/10.1016/j.apjo.2025.100137

Vancouver

Lu Y, Xie J, Cheng L, Fu Q, Wu M, Jin J, et al. Effect of substitutive growth hormone therapy on myopia control among Chinese children. Asia-Pacific Journal of Ophthalmology. 2025. doi:10.1016/j.apjo.2025.100137

BibTeX
@article{Lu2025,
  author = {Lu, Yi and Xie, Jiamin and Cheng, Lele and Fu, Qingdong and Wu, Miao and Jin, Ji and Xu, Xun},
  title = {Effect of substitutive growth hormone therapy on myopia control among Chinese children},
  journal = {Asia-Pacific Journal of Ophthalmology},
  year = {2025},
  doi = {10.1016/j.apjo.2025.100137}
}
Kostenlos starten →